Eye diseases and preventable blindness
The economic cost
Deloitte Access Economics analysed four eye diseases and blindness in sixteen countries and the cost-effectiveness of interventions. This report presents estimates for Mexico.
The economic cost and burden of eye diseases and preventable blindness in Mexico
Commissioned by Novartis Farmaceutica, S.A. de C.V this report analyses four eye diseases and blindness in sixteen countries and the cost-effectiveness of interventions to prevent eye disease and blindness.
Due to variable study quality and availability of local data, extrapolation was used in some instances from one country to another. A disease-cost burden analysis and assessment of intervention cost-effectiveness was then conducted for each country.This report presents estimates for Mexico.